re: ann - sbp002 drug kills tumours positively act I would say there are many biotechs looking at Solbecs technology . Dont forget the immune response kicks in on top of the 60% response rates from Nagourneys tests . There is not a drug in developement in Australia that comes even close to this . I would like to be a fly on the wall at BIO2004 to see who Steve Carter is talking to .
Bruce Robinson has done a great job . It pays to work with the worlds best .
SBP
solbec pharmaceuticals limited
letter to shareholders, page-9
Add to My Watchlist
What is My Watchlist?